From: Prognostic analysis for Chinese patients with stage I ovarian endometrioid carcinoma
EAC | |
---|---|
Total Number | 78 |
Age(years) | |
Mean ± SD | 48.37 ± 13.29 |
Range | 24–79 |
Menopausal status | |
Post-menopause | 31 (39.7%) |
Pre-menopause | 47 (60.3%) |
Gravid (times) | |
0 | 12 (15.4%) |
> =1 | 66 (84.6%) |
Parity (times) | |
0 | 18 (23.1%) |
> =1 | 60 (76.9%) |
Symptoms | |
Palpable mass | 23 (29.5%) |
Abdominal pain | 17 (21.8%) |
Incidental finding | 17 (21.8%) |
Irregular menstruation | 14 (17.9%) |
Postmenopausal bleeding | 8 (10.3%) |
Abdominal distension | 6 (7.7%) |
Pre-operative Ca125 value (U/ml) | |
Median(IQR) | 111.5 (58.0, 573.0) |
Range | 5.2–7600 |
Ca125 in normal range | |
Yes | 9 (11.5%) |
No | 69 (88.5%) |
Personal history | |
Breast cancer | 2 (2.6%) |
HT | 11 (14.1%) |
DM | 4 (5.1%) |
History of surgical sterilization | 4 (5.2%) |
TAH | 2 (2.6%) |
Tube ligation | 2 (2.6%) |
FIGO Stagea | |
IA | 22 (28.2%) |
IB | 4 (5.1%) |
IC | 52 (66.7%) |